Drug intelligence / Profile preview

rupixiaopian

Development stage: Preclinical
Administration: Oral

Overview

Rupixiaopian (Rupi Xiao Pian) is a traditional Chinese medicine formula commonly used for the treatment of mammary nodules and related breast disorders. It is a compound herbal preparation, with "Ru-pi-xiao" being the most frequently cited formula in clinical studies for mammary nodule disease (MMND). The formulation typically contains multiple herbal ingredients, with Bupleuri Radix often noted as a key component. Its mechanism of action is not defined by modern pharmacology but is based on traditional Chinese medicine principles aimed at resolving phlegm and dissipating nodules.

Brand names: rupixiaopianRupi Xiao Pian
Other names: Rupi Xiao PianRu-pi-xiao pian

Beyond the preview

Go deeper on rupixiaopian.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on rupixiaopian.

Explore the full profile